Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer
Journal of Clinical Oncology · 20.11.2023 · 41 (33) · 5163-5173
DOI: 10.1200/jco.22.02630 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.11.2023. Verfasst von Shukui Qin und 24 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center of Jinling Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Gemcitabine, Pancreatic Neoplasms. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
K-Ras pancreatic cancers benefit overall survival in phase 3 NOTABLE study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Center of Jinling Hospital, Nanjing, China.
- Shanghai East Hospital, Shanghai, China.
- Harbin Medical University Cancer Hospital, Harbin, China.
- The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
- The Second Hospital of Anhui Medical University, Hefei, China.
- Cancer Center of Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Shukui Qin, Yuxian Bai, Zhendong Chen, Ruihua Xu, Jianming Xu, Hongmei Zhang, Ying Yuan, Lin Yang, Lin Shen, Ying Cheng, Jun Zhang
Zitieren
APA
Qin, S., Li, J., Bai, Y., Wang, Z., Chen, Z., Xu, R., Xu, J., Zhang, H., Chen, J., Yuan, Y., Liu, T., Yang, L., Zhong, H., Chen, D., Shen, L., Hao, C., Fu, D., Cheng, Y., Yang, J., …, & Zheng, Q. (2023). Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Journal of Clinical Oncology, 41(33), 5163-5173. https://doi.org/10.1200/jco.22.02630
Vancouver
Qin S, Li J, Bai Y, Wang Z, Chen Z, Xu R, et al. Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Journal of Clinical Oncology. 2023;41(33):5163-5173. doi:10.1200/jco.22.02630
BibTeX
@article{Qin2023,
author = {Qin, Shukui and Li, Jin and Bai, Yuxian and Wang, Zishu and Chen, Zhendong and Xu, Ruihua and Xu, Jianming and Zhang, Hongmei and Chen, Jia and Yuan, Ying and Liu, Tianshu and Yang, Lin and Zhong, Haijun and Chen, Donghui and Shen, Lin and Hao, Chunyi and Fu, Deliang and Cheng, Ying and Yang, Jianwei and Wang, Qiong and Qin, Baoli and Pan, Hongming and Zhang, Jun and Bai, Xianhong and Zheng, Qingshan},
title = {Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {33},
pages = {5163--5173},
doi = {10.1200/jco.22.02630}
}
EUVIMED